Cardiovasc Drugs Ther. 2026 Jan 30. doi: 10.1007/s10557-026-07846-x. Online ahead of print.
NO ABSTRACT
PMID:41615573 | DOI:10.1007/s10557-026-07846-x
Categories
Uncertainty Regarding the Safety of SGLT-2 Inhibitors Prior to PCI: the Impact of Unmeasured Confounding and Statistical Power
